Enhanc3D Genomics Raises £10M in Series A Financing


Enhanc3D Genomics, a Cambridge, UK-based a practical genomics corporate, raised £10M in Collection A investment.

The spherical was once led by way of BGF, and Parkwalk Advisors, with participation from Bioqube Ventures.

The corporate intends to make use of the price range to boost up the improvement of its proprietary generation platform “GenLink3D“, additionally extend its crew.

Led by way of CEO Debora Lucarelli, Enhanc3D is a practical knowledge science biotech corporate whose platform, GenLink3D, targets to unencumber the opportunity of the three-d organisation of DNA. Enhanc3D’s proprietary generation without delay measures DNA interactions controlling gene legislation, permitting the exploration of the uncharted non-coding areas of the DNA, which account for roughly 98% of all of the genome. To start with, the platform will generate massive datasets throughout more than one immune-cell varieties that experience huge relevance to auto-immune illnesses, most cancers and getting old.



Leave a Comment